What are the indications for a permanent pacemaker (PPM) implantation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Permanent pacemaker (PPM) implantation is indicated for patients with symptomatic bradycardia, high-grade atrioventricular (AV) block, or specific conditions that impair the heart's electrical conduction system, as stated in the 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay 1. The primary indications for PPM implantation include:

  • Symptomatic sinus node dysfunction (sick sinus syndrome) with documented bradycardia or pauses
  • Third-degree (complete) AV block
  • Mobitz type II second-degree AV block
  • Symptomatic Mobitz type I (Wenckebach) AV block
  • Alternating bundle branch block
  • Cardiac resynchronization therapy for heart failure with reduced ejection fraction and wide QRS
  • After cardiac ablation procedures that result in AV block Additional indications include certain neuromuscular diseases with conduction abnormalities, syncope with documented pauses, and hypersensitive carotid sinus syndrome with syncope. The decision for PPM implantation is based on the correlation between symptoms and bradycardia, the severity and location of conduction disease, and the risk of progression to complete heart block, as recommended by the 2018 ACC/AHA/HRS guideline 1. PPMs work by delivering electrical impulses to stimulate the heart when the native conduction system fails, maintaining adequate heart rate and cardiac output to prevent symptoms like syncope, fatigue, and exercise intolerance that result from inadequate cerebral and systemic perfusion. In patients with symptomatic bradycardia or conduction disorder, clinicians and patients should engage in a shared decision-making approach in which treatment decisions are based not only on the best available evidence, but also on the patient’s goals of care, preferences, and values, as stated in the 2018 ACC/AHA/HRS guideline 1.

From the Research

Indications for Permanent Pacemaker (PPM) Implantation

The indications for PPM implantation are varied and depend on the underlying cardiac condition. Some of the common indications include:

  • Symptomatic bradycardia associated with sick sinus syndrome and heart block 2
  • Complete atrioventricular block 3
  • Symptomatic bradycardia/slow atrial fibrillation 3
  • Second-degree atrioventricular block 3
  • Other conduction disturbances 3
  • Sinus node dysfunction (bradycardia, sinus arrest with junctional escape) 4
  • Symptomatic complete heart block 4
  • Symptomatic sinus pause 4

Patient Characteristics and PPM Implantation

Certain patient characteristics can influence the need for PPM implantation, such as:

  • Preexisting conduction disturbances 3
  • Aortic valve replacement 3
  • Left bundle branch block 3
  • Age and gender 5
  • Index arrhythmia and initial symptoms 5

Post-Operative Care and Complications

After PPM implantation, patients require regular follow-up to monitor the device and adjust settings as needed. Complications can occur, including:

  • Pneumothorax 6
  • Arterial puncture 6
  • Electrode displacement 6
  • Pacemaker pocket infection 6
  • Generator erosion 6
  • Haematoma or serous fluid collection 6
  • Undersensing 6
  • Superficial wound infection 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pacemaker therapies in cardiology.

Australian family physician, 2007

Research

Long-term follow-up of heart transplant recipients requiring permanent pacemakers.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.